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Abstract
The glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription
factors. In contrast to many other nuclear receptors, GR is thought to be exclusively cytoplasmic in quiescent cells, and only
translocate to the nucleus on ligand binding. We now demonstrate significant nuclear GR in the absence of ligand, which
requires nuclear localisation signal 1 (NLS1). Live cell imaging reveals dramatic GR import into the nucleus through
interphase and rapid exclusion of the GR from the nucleus at the onset of mitosis, which persists into early G1. This suggests
that the heterogeneity in GR distribution is reflective of cell cycle phase. The impact of cell cycle–driven GR trafficking on a
panel of glucocorticoid actions was profiled. In G2/M-enriched cells there was marked prolongation of glucocorticoid-
induced ERK activation. This was accompanied by DNA template-specific, ligand-independent GR transactivation. Using
chimeric and domain-deleted receptors we demonstrate that this transactivation effect is mediated by the AF1
transactivation domain. AF-1 harbours multiple phosphorylation sites, which are consensus sequences for kinases including
CDKs, whose activity changes during the cell cycle. In G2/M there was clear ligand independent induction of GR
phosphorylation on residues 203 and 211, both of which are phosphorylated after ligand activation. Ligand-independent
transactivation required induction of phospho-S211GR but not S203GR, thereby directly linking cell cycle driven GR
modification with altered GR function. Cell cycle phase therefore regulates GR localisation and post-translational
modification which selectively impacts GR activity. This suggests that cell cycle phase is an important determinant in the
cellular response to Gc, and that mitotic index contributes to tissue Gc sensitivity.
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Introduction
Glucocorticoids (Gc) are essential for life, mediating a diverse
array of effects to regulate bone and glucose homeostasis, tissue
remodeling and repair, and the immune response [1]. Gc are the
most potent anti-inflammatory agents known and as such,
synthetic Gc are widely used in the treatment of inflammatory
disease. However, a major factor limiting their clinical use is the
broad variation in patient response to Gc therapy. A number of
genetic factors are known to regulate Gc sensitivity, but less is
known about how Gc sensitivity is regulated in-vivo [2–4].
Gc modulate cellular events following binding and activation of
the ubiquitously expressed intracellular glucocorticoid receptor
(GR) [1,5], a member of the nuclear hormone receptor
superfamily of ligand activated transcription factors [6–8].
In an inactive state the GR resides in the cytoplasm as part of a
multi-protein complex, which includes chaperone proteins and
immunophilins [5,9–12]. Ligand activated GR is released from this
complex and is then free to initiate non-genomic effects within the
cytoplasm, and then translocate to the cell nucleus where it
dimerises and binds palindromic Gc-response elements (GREs).
TheGR-GREcomplexhasthecapacitytorecruiteithercoactivator
or corepressor molecules that can modify chromatin and either
facilitate or inhibit transcription initiation [5,13,14]. However, the
intracellular distribution of GR is not consistently as clearly
segregated as this model would suggest, with significant nuclear
GR observed even under ligand-free conditions. Other investigators
have also shown that GR can move between cytoplasm and nucleus
when unliganded and bound to the heat shock protein complex
[15]. This aberration has also been attributed to low-level ligand
activation, but other explanations have not been explored [16–19].
The GR contains two nuclear localization sequences, NLS1,
which lies between the DNA binding domain and the ligand
binding domain, and in addition NLS2, which is less-well defined,
and lies within the ligand binding domain. NLS1 transports GR
into the nucleus in an importin a, and importin 7 dependent
manner. It now appears that import of the GR into the nucleus
may also occur when GR remains bound to the heat shock protein
complex, through interactions with the nuclear pore protein
Nup62 [20]. In contrast to the rapid rate of ligand activated
nuclear import, export of both unliganded and ligand bound GR
is a slow process, taking up to 14 hours. This has recently been
defined as resulting from a distinct nuclear retention domain that
also lies in the hinge region between the DNA binding and ligand
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22289Cell Cycle Regulation of GR Function
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22289binding domains and which acts to oppose exportin mediated
cytoplasmic relocation [21].
GR is a potent modulator of cell cycle phase, interacting with
cell cycle regulating kinases and inducing arrest at the G0/G1
checkpoint [22]. Additionally, GR activity is regulated by cell cycle
phase, with evidence for specific changes to transactivation
function, and induction of S211GR phosphorylation; although
changes to the transcriptional regulatory functions of GR in
mitosis remain controversial [23–28].
Here we show tight coupling of G1 progression to GR nuclear
translocation, with rapid exclusion at mitosis and into early G1.
This was accompanied by loss of transactivation of endogenous
target genes in mitosis-synchronised cell populations, and altered
kinetics of PKB and ERK activation. There was also a striking
increase in ligand-independent, selective transactivation of a
concatemeric reporter gene. This was due to altered function of
GR AF-1, the site of two residues known to be targets of CDKs
[19,24,25,29]. Mutation of one of these sites, serine 211, abolished
this effect, whereas mutation of the other, serine 203, had no
impact. Taken together we show strong cell-cycle phase regulation
of GR function mediated, in part, by phosphorylation of GR on
serine 211. This has clear implications for Gc action in rapidly
dividing cells.
Results
GR is subject to ligand-independent, cell cycle
dependent trafficking
Live cell imaging using a transfected fluorophore-tagged GR
(GR-EGFP) illustrates the heterogeneity of GR distribution at rest
(Fig. 1A) with some cells having strict nuclear exclusion, and others
having near equal nuclear/cytoplasmic partition. Mutation of
nuclear localisation signal 1 (NLS1, Fig. 1B) prevented any ligand-
independent nuclear accumulation rendering GR entirely cyto-
plasmic in the absence of ligand (Fig. 1C). Although ligand-
independent GR shuttling required NLS1, ligand-dependent
nuclear translocation was only partially impaired suggesting
dissociation between the two mechanisms (Fig. 1D, E).
More detailed studies identified a dramatic and unexpected
nuclear translocation that was independent of added ligand, but
synchronous with cell cycle progression (Fig. 2A). The slow rate of
nuclear import contrasts with the very rapid translocation seen in
response to ligand binding, taking hours as compared to minutes.
Peak nuclear accumulation of GR was seen immediately before
cell division and was strictly cytoplasmic following cell division
(supporting online material, Movie S1). Cross-sectional analysis of
endogenous GR intracellular distribution in fixed cells also
revealed heterogeneity in GR localisation with significant nuclear
GR in some cells at rest (Fig. 2B, C). In addition, cells immediately
post cell division, identified by rounded cell morphology and
condensed chromosomes had exclusively cytoplasmic GR, which
failed to translocate to the nucleus even in the presence of the
synthetic Gc, dexamethasone (dex, Fig. 2C). High content analysis
of fixed cells labelled with a GR antibody and DNA counter-
stained with DAPI confirms that enriching for mitotic cells by
gating with nocodazole significantly reduces the proportion of cells
where GR colocalises with DNA (Fig. 2D), suggesting exclusion of
GR from DNA. Similarly, while treatment of normally cycling
(vehicle) or Go/G1 cells (aphidicolin) with 100 nM dex for 1 hour
increases the proportion of cells that have nuclear GR, cells
sychronised with nocodazole appear refractory to Gc treatment
(Fig. 2D). This suggests an overriding physiological regulation of
endogenous GR trafficking by the cell cycle, and suggests that cell
cycle phase may be an important regulator of Gc sensitivity.
GR function is altered in mitosis
GR localisation is an important determinant in the cellular
response to Gc, and so the effect of cell cycle on GR action was
explored. In comparison to asynchronously growing cells, dex-
induction (4 hours) of the endogenous Gc target genes PDK4,
RASD1, FKBP-5, DUSP-6, MT1X and CSKN1A was signifi-
cantly impaired in cells gated with nocodazole, and released into
mitosis (Fig. 3A–F respectively).This finding is consistent with
chromatin condensation during mitosis preventing access to the
ligand activated GR. However, GR also mediates non-genomic
effects, which are not influenced by changes in chromatin
structure.
Coupling of intracellular kinases to Gc action is cell-type
specific. Treatment of A549 cells with dex induced rapid
phosphorylation of PKB. In mitosis-enriched cells the basal
activity of PKB was greatly reduced, as was the maximal
response to dex, but there was clearly still a response, and with a
similar time course in both cell populations (Fig. 4A–C).
Treatment of HeLa cells with dex-induced phosphorylation of
ERK. Interestingly, in cells enriched for mitosis by gating with
nocodazole the kinetics of ERK activation were significantly
altered, with marked prolongation of activation (Fig. 4D–F). This
difference suggests a selective change in GR function dependent
on cell cycle phase.
A series of transient reporter gene assays were undertaken to
provide a robust measure of GR activity independent of
potentially non-specific effects due to chromosome condensation.
MMTV (pAH3-luc) is a simple GR dimer dependent transactiva-
tion target for GR, and NFkB (NRE-luc) is a consensus NFkB
target gene subject to Gc repression by a tethering mechanism
requiring GR interaction with RelA [19,23,30]. Neither MMTV-
luciferase (pAH3-luc, Fig. 5A) or NFkB-luciferase (NRE-luc,
Fig. 5B) reporter genes showed any significant effect of cell cycle
synchronisation on response to Gc treatment. There was however
a marked and consistent induction in ligand-independent
transactivation of the simple TAT3-luc reporter, which comprises
three tandem repeats of a consensus GRE upstream of a minimal
promoter [30,31] (Fig. 5C). This effect was specific to G2/M
synchronisation, since it was evident in cells gated at G2/M with
nocodazole, and then released into mitosis, but not with
aphidicolin treatment (Fig. 5C) which synchronises cells in G1.
This effect was also GR specific, as ligand-dependent induction of
TAT3-luc in GR deficient HEK cells required exogenous GR
(Fig. 5D).
To explore the role of the GR DNA binding domain (DBD) a
chimeric GR was used, where the GR DBD was substituted for the
Figure 1. Ligand-independent Gr nuclear translocation requires NLS1. (A) HeLa cells were transfected with 1 mg EGFP-GRa and cultured in
growth media containing 10% charcoal dextran stripped FCS (CSS). (B) An NLS deficient GR (GRNLS1-) was generated by site directed mutagenesis.
NTD; N-terminal domain, DBD; DNA binding domain, H; hinge region, LBD; ligand binding domain. (C) HeLa cells were transfected with 1 mg EGFP-
GRNLS1- and cultured in growth media containing 10% CSS. (D) HeLa cells were transfected with 1 mg EGFP-GRa or EGFP-GRNLS1- and cultured in
growth media containing 10% CSS alone, or in the presence of 10 nM dex (time indicated in minutes). (E) Cells were analysed for GR localisation in
real time and nuclear translocation of Wt GR and GRNLS1- quantified as a nuclear/cytoplasmic ratio. In A and C, multiple representative fields are
shown.
doi:10.1371/journal.pone.0022289.g001
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Although wildtype ER transactivates ERE-luc in response to
estradiol, the GR-ER chimera (GEG) fails to respond to estradiol
(Fig. 6B) and instead binds, and transactivates ERE-luc in response
to dex. These studies revealed that the ligand-independent activity
of GR with G2 synchronisation was still evident following
Figure 2. Subcellular GR localisation is synchronous with cell cycle phase. (A) HeLa cells were transfected with 1 mg EGFP-GRa and cultured
in growth media containing 10% CSS. Cells were analysed for GR localisation in real time. Cells received no treatment, therefore time is indicated in
hours from an arbitrary start point. (B, C) Unsynchronised HeLa cells cultured in CSS were treated with vehicle or 100 nM dex for 1 hour, then fixed
and endogenous GR labelled (red). DNA was counterstained with DAPI (blue). Representative images of mitotic cells (indicated by arrows) are shown.
(D) HeLa cells cultured in CSS were treated with vehicle (Veh), aphidicolin (Aphi) or nocodazole (Noc) for 15 hours, then washed and incubated with
vehicle or 100 nM dex for an additional 1 hour. Cells were fixed with PFA, endogenous GR labelled using a specific antibody and DNA stained with
Hoechst. Cells were subjected to high content analysis using an algorithm which analysed GR subcellular distribution against DNA distribution
(nucleus in interphase cells, and condensed chromosomes in mitotic cells). Graph depicts mean +/2 SD of three independent experiments performed
in duplicate (.40,000 cells in each case). * indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g002
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suggested that the mitosis specific GR activation was mediated
through either the C terminal LBD or the GR N terminal which
contains the major transactivation domain, AF-1. Deletion
constructs for both GR C and N terminal domains were used
(Fig. 6D). These showed that loss of the C terminal resulted in a
constitutively active transactivator on which no cell cycle effect was
observed (Fig. 6E). Loss of GR AF-1 also abolished the ligand-
independent transactivation of the TAT3-luc reporter (Fig. 6F).
This implicates the GR AF-1 as the target for cell cycle regulation
of GR function.
S211GR is required for cell cycle dependent, ligand-
independent activity
The AF-1 domain harbours multiple phosphorylation sites. The
two best-characterised phosphorylation sites in the GR AF-1
domain are serines 203 and 211, both of which are important
modulators of GR-mediated transactivation [24]. Using phospho-
specific antibodies we demonstrate a ligand independent induction
of both phospho-S211GR (Fig. 7A, B) and phospho-S203GR
(Fig. 7A, C) that is specific to mitotic cell cycle arrest (nocodazole-
and taxol-gating), rather than a consequence of cell cycle arrest,
since aphidicolin, hydroxyurea and roscovitine which arrest earlier
in the cell cycle were without effect. Interestingly, the magnitude of
either S203GR or S211GR phosphorylation following mitotic
arrest was similar to that seen following 1 hour dex treatment
(Fig. 7A–C).
Examination of individual cells within a normally cycling
population reveals a striking and very specific induction of both
S211GR (Fig. 8A) and S203GR (Fig. 8B) phosphorylation in
mitotic cells when compared to surrounding, non-dividing cells.
Immunoprecipitation-immunoblotting experiments were used to
confirm the specificity of both the phospho-S211GR (Fig. 8C)
and S203GR (Fig. 8D) antibodies, and also show induction
of GR phosphorylation in mitosis-enriched cell populations
(Fig. 8C, D).
To determine if either of these sites were responsible for the
ligand-independent activity of GR on TAT3-luc, point mutations
of these two phosphorylation sites were generated, substituting
serine for either alanine (S to A) or aspartate (S to D) to generate
phosphodeficient or phosphomimetic mutants respectively. The
point mutated GR expression vectors were co-transfected with
TAT3-luc into cells deficient in endogenous GR, HEK293 cells.
Mutation of serine 203 to alaninine (A203GR) or aspartate
(D203GR) had no effect on the induction of TAT3-luc
transactivation observed in mitosis-enriched cells (Fig. 9A). In
contrast mutation of serine 211 completely abolished the effect of
mitosis. A211GR failed to induce the mitosis dependent increase
in reporter gene activity and D211GR promoted ligand
independent GR transactivation, where no further induction was
seen in nocodazole gated cells (Fig. 9B). Neither phosphodeficient
A211GR, nor phosphomimetic, D211GR impaired Gc mediated
transactivation of the reporter gene. These data suggest that
induction of phospho-S211GR in mitosis drives ligand-indepen-
dent GR activation.
Figure 3. GR transactivation is dependent on cell cycle phase. HeLa cells were treated with nocodazole for 16 hours, washed and released
into mitosis in the presence of vehicle or 100 nM dex for 4 hours. Cells were lysed, RNA extracted and analysed by qPCR using primers specific to
PDK4 (A), RasD1 (B), FKBP5 (C), Dusp6 (D), MT1X (E) and CSKN1A (F). Graphs depict mean +/2 SEM and are representative of three independent
experiments. * indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g003
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in a marked increase in the frequency of phospho-S211GR
positive cells, and that the phospho-211GR positive cells will
correlate with mitotic cell numbers. To test this we gated cells
using nocodazole (Fig. 10A, B), and either performed immediate
analysis, or released the cells from nocodazole block in order to
enable them to complete mitosis. The cells released showed a
decrease in mitotic cells (Fig. 10B) suggesting progression through
mitosis, an induction of tubulin (Fig. 10C) indicating reversal of
tubule poison effects, and a concomitant decrease in phospho-
S211GR positive cells (Fig. 10D). This was supported by FACS
analysis (Fig. 10E).
Mitotic gating with nocodazole followed by release into either
vehicle or a range of kinase inhibitors for 1 hour prior to fixation
implicates CDK and ERK MAP kinases, but not p38 or JNK
MAPK in driving the increase in S211GR phosphorylation
(Fig. 10F).
Given the significant increase in S211GR phosphorylation in
mitotic cells, a possibility is that in cells with mitosis-driven
phosphorylation of GR at Ser211 there would be no further
augmentation of GR phosphorylation seen in response to ligand
binding. Accordingly, cells were gated with nocodazole, and
released with or without Gc treatment. Nocodazole caused the
predicted induction of phospho-S211GR, and there was no further
increase seen with Gc incubation, in contrast to the control
interphase cells which showed low basal phosphorylation, and
rapid induction following Gc exposure (Fig. 11). Cell cycle phase is
therefore an important regulator of GR activity, in both the
liganded and unliganded state.
Taken together we define cell cycle driven subcellular GR
trafficking and post-translational modification which in turn drive
specific changes in GR function that alters the cellular response to
Gc.
Discussion
This study aimed to define the mechanism underlying nuclear
trafficking of the ligand free GR, and the consequences of such
trafficking for the cell. We now report direct coupling of cell cycle
progression to GR subcellular localisation, phosphorylation and
function.
Real time imaging studies in normally cycling cells demonstrat-
ed NLS1-dependent, ligand-independent shuttling of GR between
the nucleus and cytoplasm where GR was nuclear in interphase
cells, and strictly cytoplasmic immediately following completion of
mitosis. Analysis of cells during mitosis showed exclusion of bulk
GR from condensed chromosomes. These observations were made
in cells expressing an GFP tagged GR, but compatible findings
were present in untransfected cells, either grown asynchronously,
or in the presence of cell cycle synchronisation agents. By using
these various approaches we were able to exclude the impact of
GR expression levels, fixation method, and also the potential
effects of spindle toxins on the distribution and trafficking of the
GR.
In these studies cells immediately post mitosis showed
cytoplasmic GR, even in the presence of Gc. This observation
conflicts with the accepted view that GR remains cytoplasmic until
activated by ligand. However, the kinetics of rapid export at the
onset of mitosis, slow import through G1 and the requirement of
NLS1 for these ligand-independent effects all suggest a mechanism
distinct from ligand-induced GR trafficking.
In interphase cells the movement of GR from the cytoplasm to
the nucleus in response to ligand binding follows rapid kinetics,
with complete translocation within minutes [19,15]. This mech-
anism requires binding of importin a, and association with the
nuclear pore complex. More recent studies have suggested
constitutive trafficking of non-ligand bound GR, in association
with heat shock proteins, through the nuclear pore, with the steady
state distribution determined by fine tuning of import and export
rates [15,20]. Ligand bound GR remains nuclear for hours even
after ligand withdrawal, a phenomenon now attributed to a
specific nuclear retention signal close to but separable from the
NLS1 in the hinge region [21]. Therefore, the paradoxical kinetics
of movement observed in our studies is striking, with slow kinetics
of nuclear import through G1, and very rapid expulsion of the GR
from the nucleus immediately before mitosis, with persisting strict
exclusion in early G1 in the resulting daughter cells.
There have been a number of previous reports relating cell cycle
phase to GR function, including hormone binding, nuclear
translocation, post-translational modification, and transcriptional
regulatory activity [27,28,32–36]. Previously the effect of cell cycle
phase has principally focussed on the transcriptional regulatory
activity of the GR. There have been some inconsistencies in the
literature, as various cell synchronisation protocols have been used
which may have other toxic effects on target cells [28]. This has
remained controversial, with studies suggesting that mitotic
repression of GR transcriptional activity is a non-specific
consequence of chromatin condensation [28], and that GR would
function correctly if chromatin were more readily accessible.
Cell synchronisation with nocodazole, followed by release into
mitosis with or without Gc clearly demonstrated impaired
induction of six Gc regulated index genes, when compared to
asynchronous cell populations. These results are certainly
compatible with some of the earliest observations of impaired
Gc action in mitosis [37,38], but mechanistic insight is limited due
to the effects of chromosome condensation.
Therefore, we have also defined rapid non-transcriptional GR
effects which would not be affected by chromosome condensation.
HeLa cells show non-genomic coupling of Gc to ERK
phosphorylation, whereas in A549 cells there is coupling to
PI3kinase [23]. Nocodazole synchronisation altered the kinetics of
activation of MAP kinase in HeLa cells, and exerted a global
inhibition of PKB phosphorylation in A549 cells so that while
there was still an induction in PKB phosphorylation following Gc
treatment, the magnitude of response was reduced. This implied a
specific alteration in GR-kinase coupling in mitosis enriched cell
populations, suggestive of a change in function rather than an
effect mediated by steric hindrance of GR binding to target sites in
the genome. Whilst promising, a semi-quantitative technique is not
suitable to map potentially small changes in GR activity, and so a
more sensitive model was sought.
GR is a ligand activated transcription factor, and as such
transcriptional effects of Gc are the best characterised. A transient
reporter gene system was selected as the construct was not
chromatinised, and so not subject to condensation. We chose to
use three well-characterised, simple reporter genes. MMTV and
Figure 4. GR regulation of kinases is dependent on cell cycle phase. A549 (A–C) or HeLa (D–F) cells were treated with vehicle or nocodazole
for 16 hours, washed and released into mitosis in the presence of 100 nM dex for up to 60 minutes. Cells were lysed and immunoblotted for
phospho-PKB and PKB (A), or phospho-ERK and ERK (D). Immunolabelling was quantified by densitometry using ImageJ, where both cell cycle effects
(B, E) and Gc-dependent effects (C, F) on kinase activity are depicted. * indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g004
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differential response to targeted mutations that disrupt dimerisa-
tion [31,39,40]. In addition, we chose an NFkB reporter gene, as
this is repressed by monomeric GR binding to the RelA
component of NFkB [30].
We observed no cell cycle effect on transactivation of an
MMTV reporter gene or transrepression of an NFkB reporter.
However, there was a striking induction of ligand independent
promoter activity of a simple reporter consisting of three repeats of
the tyrosine aminotransferase GRE; TAT3-Luc.
Figure 5. Endogenous GR activity is altered in mitosis. (A–C) HeLa cells were transfected with either 1 mg AH3-Luc (A), NRE-Luc (B) or TAT3-Luc
(C) and 0.5 ug CMV-renilla (to control for transfection efficiency). Cells were treated with nocodazole or aphidicolin for 16 hours, then washed and
treated with appropriate vehicle, 0.5 ng/ml TNFa (NRE-luc only) and/or dex for 16 hours. Cells were lysed, harvested and assayed for luciferase
activity using a dual-luciferase reporter assay system. (D) GR deficient HEK cells were co-transfected with 1 mg TAT3-Luc and 0.5 mg CMV-renilla (to
control for transfection efficiency) together with 1 mg full length GR (GR) or empty vector (Con). Cells were treated with vehicle or nocodazole for
16 hours, then washed and treated with vehicle or dex for 16 hours. Cells were lysed, harvested and assayed for luciferase activity using a dual-
luciferase reporter assay system. Graphs depict mean +/2 SEM and are representative of three independent triplicate experiments. * indicates p,0.05
compared to vehicle control.
doi:10.1371/journal.pone.0022289.g005
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22289Figure 6. GR N-terminal is regulated by mitosis. (A) A GR-ER chimera was used which comprises the GR N- and C-terminus and the ER DNA
binding domain. (B, C) HeLa cells were co-transfected with a receptor chimera (GEG), together with 1 mg of the estrogen receptor responsive reporter
ERE-Luc and 0.5 mg CMV-renilla (to control for transfection efficiency). 24 hours later, cells were treated with vehicle or nocodazole for 16 hours, then
washed and treated with vehicle, estradiol or dex for 16 hours. Cells were lysed, harvested and assayed for luciferase activity using a dual-luciferase
reporter assay system. (D) Two deletion mutant receptors were used which lack either the C-terminal ligand binding domain (GRN500) or the AF-1
domain within the N-terminus (GRdAF1). To minimise confounding effects of wildtype endogenous GR in HeLa cells, GR deficient HEK cells were used
in this instance. HEK cells were co-transfected with 1 mg TAT3-Luc and 0.5 mg CMV-renilla (to control for transfection efficiency) together with either
1 mg full length GR, GRN500, (E), or GRdAF1 (F). 24 hours later, cells were treated with vehicle or nocodazole for 16 hours, then washed and treated
with vehicle or dex for 16 hours. Cells were lysed, harvested and assayed for luciferase activity using a dual-luciferase reporter assay system. Graphs
depict mean +/2 SEM and are representative of three independent triplicate experiments. * indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g006
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the theory of a specific, regulated, potentially reversible change
to GR that would modify the cellular response to Gc. To define
the underlying mechanism, a series of GR deletants, and
chimeras were used. These revealed a cell cycle driven
transactivation function localised to the GR N-terminal AF-1
domain. The AF-1 domain contains the major transactivation
function of the GR, and is known to be a site of post-
translational modification.
We went on to show that within the GR AF-1 domain two
residues, serine 203 and serine 211, are phosphorylated both in
response to ligand activation, and following entry into mitosis. We
were able to show induction of phospho-S203GR and -S211GR
by immunoblot analysis after gating with nocodazole, and also in
naturally cycling populations of cells by immunofluorescence.
FACS and high content cell imaging demonstrated that all mitotic
cells underwent ligand-independent S211GR phosphorylation,
suggesting no additional factors were required.
The cell cycle phase regulation of S211GR phosphorylation was
dominant over ligand induced changes, as shown by comparing a
time course of dex induction of phospho-S211GR in the presence
and absence of nocodazole synchronisation.
There is evidence from the literature that CDK, and p38 MAP
kinases can phosphorylate GR on S211 [29,41]. During mitosis
CDKs are activated, and are therefore highly likely to be playing
an important role. Although inhibition of p38 had no effect, we
show that inhibition of either CDK, or ERK, impairs S211
phosphorylation in mitosis. A more comprehensive analysis was
not possible as complete ablation of CDK or ERK activity also
impacted cell cycle progression.
Closer examination of cells in mitosis revealed differential
distribution of phospho S203GR, and phospho S211GR, with
phospho S203GR localised to the spindle poles, and phospho
S211GR aligning along the condensed chromosomes. This
differential distribution of the two phosphoforms has not been
observed before in mitosis. In interphase cells however, the two
phospho marks appear to identify different sub-populations of GR
[42], perhaps suggesting a common targeting mechanism for GR
in mitotic and interphase cells.
There was a notable decrease in total GR immunoreactivity in
nocodazole gated cells. This was a consistent and robust finding.
This would provide a very simple explanation for a loss of GR
function. However in mitosis we did not observe a global
reduction in Gc actions but show very selective effects, in
particular on GR-kinase coupling and transactivation of TAT3-
luc. This is not compatible with downregulation of GR. It does
raise the possibility however that phosphorylation of GR in
mitosis couples the GR to ubiquitination, and degradation, in a
similar manner to that described for the ligand bound, and
activated GR.
We predicted that the cell-cycle dependent, ligand-independent
transactivation may be mediated through phosphorylation of one
or both of these residues, and the subsequent recruitment of co-
modulator proteins such as MED14 [24,43]. The mediating role of
S211GR and S203GR phosphorylation events were defined using
site directed mutagenesis in GR deficient HEK293 cells. These
studies revealed that S203GR played no role, but in contrast
S211GR to A211GR substitution completely abolished the ligand
independent induction of promoter activity, and the phosphoS
mimetic D211GR induced promoter activity above that seen with
wild-type GR, where no further induction was seen in mitosis.
S211GR phosphorylation therefore selectively mediates the cell
cycle dependent, ligand-independent induction of transactivation.
It is perhaps not surprising that induction of phospho-S211GR
was important for transactivation, as it is already known that this
modification is required for GR binding to certain DNA targets
[42,43].
Demonstration of ligand-independent transcriptional regulation
by the GR has also been recently described in epithelial cells
Figure 7. Synchronisation in mitosis induces GR phosphoryla-
tion. (A) HeLa cells were treated for 16 hours with either vehicle (Veh),
aphidicolin (Aphi), hydroxyurea (HxUR), roscovitine (Rosc), taxol (Tax) or
nocodazole (Noc) then lysed and immunblotted for GR, phospho-
S203GR (S203GR), phospho-S211GR (S211GR) and tubulin. 1 hour
treatment with 100 nM dex was used as a positive control.
Immunoreactive bands for S211GR (B) and S203GR (C) were quantified
by densitometry using ImageJ. Representative images are shown.
* indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g007
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requires phosphorylation of S226, and not S211, and no role for
cell cycle is proposed [44]. Therefore, our findings are entirely
novel, but certainly not incompatible.
Regulation of cell cycle progression and cell fate [19] is
mediated by direct transcriptional regulation of p27KIP and cyclin
D expression by GR and is one of the conserved actions of Gc. We
now show that additionally the cell cycle feeds back to regulate GR
modification, cellular trafficking and function, independent of
externally derived ligand. This implies a cyclic, reversible change
to GR which alters the cellular response to Gc and correlates with
progression through the cell cycle. Our data indicates that
maximal Gc effects are likely to occur in interphase cells, which
also suggest a potential feed-forward circuit where G0/G1 cell
cycle arrest mediated by Gc augments the cellular response to
subsequent Gc exposure.
Here we show that cell cycle phase exerts a regulatory activity
on the function of the GR. The physiological consequences of cell
cycle driven GR trafficking, modification, and ligand independent
activation are likely to be important. Clearly, many cumulative
factors play a role in determining Gc sensitivity. The tight coupling
of mitotic index, S211GR phosphorylation and GR activity may
represent a very basic level regulation. Further dissecting how
reversible modification of GR impacts Gc sensitivity, and
delineating additional regulatory mechanisms will be invaluable
to understanding the mechanisms that regulate Gc responsiveness
of tissues.
Materials and Methods
Anti-GR (clone 41) from BD Biosciences (Oxford, UK); anti-
S203GR from AbCam (UK); anti-S211GR, anti-PKB, anti-
PPKB, anti-ERK and anti-PERK from Cell Signalling Technol-
ogy (MA, USA); anti-atubulin from Sigma (Poole, UK);
horseradish peroxidase conjugated anti-mouse and anti-rabbit
from GE Healthcare (Buckinghamshire, UK); Alexa 546 conju-
gated anti-mouse and Alexa 488 conjugated anti-rabbit from
Invitrogen (Paisley, UK). Dexamethasone and estradiol from
Sigma (Dorset, UK). Nocodazole, aphidicolin, HxUR, SB202190
(p38i), JNK inhibitor VIII (JNKi), PD98059 (MEKi) and
roscovitine (CDKi) from Calbiochem (UK). TAT3-Luc, AH3,
ERE-Luc, EEE, GEG, GGG, and pEGFP-GRa have been
Figure 8. GR is phosphorylated in mitotic cells. Untreated HeLa cells cultured in CSS were double labelled with antibodies specific to tubulin
and phospho-S211GR (S211GR, A) or phospho-S203GR (S203GR, B) and DNA counterstained with DAPI. Representative images of mitotic cells within
a mixed population are shown. (C, D) HeLa cells were treated with vehicle (Veh) for 16 hours or synchronised with nocodazole (Noc) for 16 hours,
then washed and released into mitosis. Vehicle treated cells were scraped into RIPA buffer and a pure population of mitotic cells collected from the
nocodazole treated population by shake off, then pelleted and lysed in RIPA. Lysates were immunoprecipitated for GR or control IgG and precipitates
electrophoresed and immunoblotted for GR together with phospho-S211GR (C) or phospho-S203GR (D). Images and immunoblots are representative
of at least three independent experiments.
doi:10.1371/journal.pone.0022289.g008
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request.
Cell line generation, culture and maintenance
Human cervical carcinoma cells (HeLa; ECACC, Wiltshire,
UK), lung epithelial cells (A549, ECACC) and embryonic kidney
cells (HEK, ECACC) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing Glutamax supplemented
with 10% charcoal dextran stripped fetal calf serum (CSS,
Invitrogen). Cells were maintained in a humidified atmosphere
of 5% CO2 at 37uC.
Cell cycle arrest
Cells were enriched for G2/M checkpoint using 16 hour
treatment with the microtubule disrupting drug nocodazole, or
the microtubule stabilising drug Taxol. Following accumulation of
cells at G2/M checkpoint, they were carefully washed with serum
free media, then returned to full culture media containing
10%CSS then treated as required. Following this, mitotic spindles
reformed, and cells progressed into mitosis. All treatments were
therefore conducted in cells with an intact microtubule network.
Cells were also growth arrested using Hydroxyurea, Roscovitine,
and Aphidicolin treatment for 16 hours. They were also carefully
Figure 9. Mitosis driven phosphorylation modifies GR activity. To minimise confounding effects of wildtype endogenous GR in HeLa cells, GR
deficient HEK cells were used in this instance. (A, B) HEK cells were co-transfected with 1 mg TAT3-Luc and 0.5 mg CMV-renilla (to control for
transfection efficiency) together with either wildtype GR (S203GR, S211GR), a phosphorylation deficient receptor (A203GR, A211GR) or a
phosphorylation mimic (D203GR, D211GR). 24 hours later, cells were treated with vehicle or nocodazole for 16 hours, then washed and treated with
vehicle or dex for 16 hours. Cells were lysed, harvested and assayed for luciferase activity using a dual-luciferase reporter assay system. Graphs depict
mean +/2 SEM and are representative of three independent triplicate experiments. * indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g009
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containing 10%CSS before treatment.
Site directed mutagenesis
GR constructs with point mutations at S203 (A203GR,
D203GR) and S211 (A211GR, D211GR) and the NLS deletant
(GRNLS-) were generated using a quick change II site directed
mutagenesis kit (Stratagene) using manufacturers instructions.
Real-time fluorescent cell imaging
10
5 HeLa cells were transfected with EGFP-GRa (1 mg) using
Fugene 6 reagent (3:1 v/w ratio). 24 hours post transfection cells
were trypsinised and seeded at a density of 10
5 cells per 35 mm
glass-bottomed plate (Iwaki, Japan). Cells were imaged 24 hours
after transfection on a Zeiss LSM510 Axiovert 200 M equipped
with an XL incubator (maintained at 37uC, 5% CO2, in humid
conditions) through a 636 objective (numerical aperture, 1.4;
Zeiss). Excitation of EGFP was performed using an argon ion laser
at 488 nm. Emitted light was captured through a 505–550 nm
bandpass filter from a 540 nm dichroic mirror. Images were taken
at regular intervals and data captured and analyzed using
LSM510 software (Zeiss).
Immunofluorescence
Cells were treated as specified in the results, fixed with 4%
paraformaldehyde (PFA) for 30 minutes at 4uC, then permeabi-
lised (0.02% Triton X-100 in PBS) for 30 minutes at room
temperature (RT). Fixed cells were blocked (1% FCS in PBS) for
4 hours at RT with agitation, then in primary antibody (diluted in
blocking buffer) overnight at 4uC. After three 10 minute washes in
PBS cells were incubated in secondary antibody (diluted in PBS)
for 2 hours. After incubation with Hoechst for 10 minutes,
coverslips were washed three times and mounted using Vecta-
shield aqueous hard set mountant (Vector Laboratories, Peterbor-
ough, UK). Images were acquired on a Delta Vision RT (Applied
Precision) restoration microscope using a 606/1.42 Plan Apo
objective and the Sedat filter set (Chroma 89000). The images
were collected using a Coolsnap HQ (Photometrics) camera with a
Z optical spacing of 0.5 mm. Raw images were then deconvolved
using the Softworx software and maximum intensity projections of
these deconvolved images processed using ImageJ. The fluorescent
intensities of nucleus and cytoplasm were compared, and the ratios
presented.
High content analysis
High Content Analysis was performed in the laboratories of
Imagen Biotech (Manchester, UK) on an Arrayscan II (Cellomics,
Thermofisher, USA). Cells were plated into glass bottomed 96-well
plates and processed as outlined in ‘Immunofluorescence’. The
percentage of mitotic cells was calculated based on a threshold of
average nuclear intensity and the arrayscan compartmental
analysis algorithm (Cellomics) used to determine the intensity of
endogenous GR and phospho-S211GR staining. Measurements of
GR subcellular distribution in mitotic and non-mitotic cells were
established using appropriate nuclear gating.
Immunoprecipitation
Whole cell extracts (500 mg protein) were pre-cleared with
protein A/G-coated sepharose beads. In the test samples,
supernatant was incubated with 5 mg primary antibody and
protein A/G-coated sepharose beads overnight at 4uC. The
control sample supernatants were incubated with protein A/G-
coated sepharose beads and IgG from non immunised animals.
Following incubation, protein A/G-coated sepharose beads were
collected by centrifugation (1800 g) and washed three times
(5 minutes) with ice-cold PBS. Samples were boiled for 5 minutes
in reducing loading buffer, and the beads removed prior to
electrophoresis.
Immunoblot analysis
Cell lysates or immunoprecipitates were electrophoresed on 4–
12% Tris-Glycine gels (Invitrogen) and transferred to 0.2 micron
nitrocellulose membranes (BioRad Laboratories, Hertfordshire,
UK) overnight at 4uC. Membranes were blocked for 6 hours
(0.15 M NaCl, 1% dried milk, 0.1% Tween 20) and incubated
with primary antibodies (diluted in blocking buffer) overnight at
4uC. After three 10 minute washes (88 mM Tris pH 7.8, 0.25%
dried milk, 0.1% Tween 20), membranes were incubated with a
species-specific horseradish peroxidase-conjugated secondary an-
tibody (diluted in wash buffer) for 1 hour at RT, and washed a
further three times, each for 10 minutes. Immunoreactive proteins
were visualised using enhanced chemiluminescence (ECL Ad-
vance, GE Healthcare).
FACS analysis
For DNA quantification, cells were trypsinised and the cell
suspension combined with equal volumes of 100% ice-cold ethanol
for 1 hour at 4uC. Cells were pelleted at 1500 g for 10 minutes
and resuspended in 200 ml PBS. 50 ml DNAse free RNAse A
(1 mM) was added to each sample and incubated at RT for
30 minutes. 50 ml propidium iodide (1 mM) was added prior to
analysis. For antibody labelling, cells were trypsinised then fixed
with 4% PFA for 1 hour at 4uC. Cells were post-fixed in ice-cold
50% methanol (1 hour), washed three times with PBS then
blocked for 1 hour (5% FCS, 0.001% Triton-X-100, PBS). Cells
were incubated in primary antibody for 1 hour (diluted in block)
washed three times with PBS then incubated with secondary
antibody for 30 minutes (diluted in block). Cells were washed three
times in PBS prior to analysis (Beckman Coulter Cyan ADP,
488 nm excitation; 530/40 nm bandpass, 635 nm excitation;
Figure 10. Induction of GR phosphorylation directly correlates with mitotic index. HeLa cells cultured in CSS were treated with vehicle
(Veh), aphidicolin (Aphi), nocodazole for 16 hours (Noc) or nocodazole for 15 hours followed by vehicle for 1 hour (Noc Rel) and fixed with PFA. Cells
were double labelled with antibodies specific to tubulin and phospho-S211GR, and DNA counterstained with Hoechst. Representative images of
S211GR are shown (A). Cells were gated according to DNA content, and the percentage of mitotic cells (B), average tubulin intensity (C) and induction
of phospho-S211GR (D) measured using a high content algorithm. Graphs depict mean +/2 SEM of three independent triplicate experiments
(.100,000 cells). (E) HeLa cells were treated with vehicle (Veh) for 16 hours or synchronised with nocodazole (Noc) and released into mitosis.
Asynchronously dividing vehicle cells were collected following trypsinisation and nocodazole treated mitotic cells were collected by shake off.
Samples were divided into two, and either fixed with ethanol or PFA, followed by methanol. Ethanol fixed samples were stained with PI then analysed
by FACS for DNA content and PFA/Methanol fixed cells were labelled with a phospho-S211GR specific antibody or rabbit IgG and analysed by FACS
for phospho-S211GR staining. (F) HeLa cells cultured in CSS were treated with nocodazole (Noc) for 15 hours followed by vehicle for 1 hour together
with 10 mM kinase inhibitor (as indicated) and fixed with PFA. Cells were double labelled with antibodies specific to tubulin and phospho-S211GR,
and DNA counterstained with Hoechst. Representative images of S211GR are shown. Cells were gated according to DNA content and phospho-
S211GR measured using a high content algorithm. Graphs depict mean +/2 SEM of three independent triplicate experiments (.100,000 cells).
* indicates p,0.05 compared to vehicle control.
doi:10.1371/journal.pone.0022289.g010
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v4.3 software.
Reporter gene assay
Cells were co-transfected with 1 mg ligand-regulated Tat3-,
AH3-, NRE- or ERE- firefly luciferase reporter gene construct
together with 0.1 mg CMV-renilla luciferase (a consitutively
expressed enzyme that controls for transfection efficiency) using
Fugene 6. 24 hours later cells were treated as specified in results
prior to lysis, then assayed for luciferase activity using a dual-
luciferase reporter assay system following manufacturers instruc-
tions (Promega, Southampton, UK), and as previously described
[45].
q-RTPCR
HeLa cells were treated as specified in results, then lysed and
RNA extracted using an RNeasy kit (Qiagen). RNA quality was
established using an Agilent bioanalyser. 10 ng RNA was reverse
transcribed, and subjected to qPCR using Sybr Green detection in
an ABI q-PCR machine and data analysed by ddCT method as
previously described [30].
Supporting Information
Movie S1 Real time imaging depicted in figure 2A. HeLa
cells were transfected with 1 mg EGFP-GRa and cultured in
growth media containing 10% CSS. Cells received no treatment
and were analysed for GR localisation in real time. GR trafficking
is under cell cycle control and undergoes repeated cycles of
shuttling between the cytoplasm and nucleus.
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